Jonathan Jenkins to Lead Digital, AI Initiatives at Trinity Life Sciences

Trinity Life Sciences has appointed former QuantumBlack leader Jonathan Jenkins to accelerate its artificial intelligence (AI) and digital efforts.

“Trinity’s AI focus has always been through the lens of business value—pinpointing what business problems can be solved more quickly with more inputs to deliver richer insights,” Trinity Life Sciences President/CEO Leslie Orne said. “We are delighted to appoint Jonathan to lead these vital initiatives and to leverage his considerable experience in shaping and scaling innovative AI approaches that impact value in life sciences.”

Life sciences organizations are in pursuit of fast, insightful answers across the lifecycle from new product planning, launch, and in-line asset management through to customer engagement. Trinity’s depth in areas such as forecasting and primary market research allows these approaches to be enhanced by AI, providing greater insight into key business questions that assess potential outcomes.

Jenkins brings extensive experience in addressing business priorities by establishing scalable foundations across data, AI, tech, capabilities, processes, and culture. A pioneer in embedding AI in healthcare, he has worked with providers, payers and governments as well as life science companies in the United States, Europe, Asia, and the Middle East on data and AI strategy. Previously, Jenkins was a partner in McKinsey’s life science practice and a core leader in QuantumBlack, defining its approach to productizing life sciences analytics.

“Trinity’s strategy heritage and proprietary data, including primary research and benchmarks, puts us in a unique position to create opinionated AI applications and products on questions that matter,” stated Jenkins, head of Digital & AI Solutions. “I’m motivated by addressing meaningful challenges at scale with multi-disciplinary teams, so bringing together Trinity’s diverse expertise to create transformational offerings is a special opportunity that I’m honored to lead.”

With nearly 30 years of expertise and access to data and analytics, Trinity Life Sciences combines strategy, insights, and analytics to help life science executives with clinical and commercial decision-making. The firm serves more than 300 pharmaceutical, biotech, and medical device clients, helping them develop the right drugs and devices for the market and optimize them upon commercialization. Trinity Life Sciences employs more than 1,200 workers and maintains 11 offices in the United States, Europe, and Asia.